What UNITED THERAPEUTICS Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 851 | 2,860 |
| Total trades | 923 | 3,194 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 640,140 | 2,757,972 |
| Disposed | 640,238 | 2,781,480 |
| Net activity | −98 | −23,508 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −280 | $597.33 | −$167K | 324,443 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −662 | $596.22 | −$395K | 324,723 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −1,409 | $595.17 | −$839K | 325,385 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −3,079 | $594.24 | −$1.83M | 326,794 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −1,934 | $593.44 | −$1.15M | 329,873 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −551 | $592.32 | −$326K | 331,807 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −317 | $591.10 | −$187K | 332,358 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −359 | $590.11 | −$212K | 332,675 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −427 | $589.21 | −$252K | 333,034 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −323 | $588.30 | −$190K | 333,461 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Open-market sale · S | −159 | $587.00 | −$93.3K | 333,784 |
| Rothblatt Martine A | Chairperson & CEO | Nov 12 | Exercise / conversion · M | +9,500 | $117.76 | +$1.12M | 333,943 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −247 | $598.63 | −$148K | 324,443 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −1,299 | $597.61 | −$776K | 324,690 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −1,324 | $596.74 | −$790K | 325,989 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −1,346 | $595.46 | −$801K | 327,313 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −991 | $594.66 | −$589K | 328,659 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −961 | $593.57 | −$570K | 329,650 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −1,172 | $592.68 | −$695K | 330,611 |
| Rothblatt Martine A | Chairperson & CEO | Nov 11 | Open-market sale · S | −736 | $591.56 | −$435K | 331,783 |
Loading...